A new test delivers a higher standard of cardiac care in the Emergency Room The Elecsys ® Troponin T Gen 5 STAT (TnT Gen 5 STAT) is the first highly sensitive Troponin T biomarker test cleared by the Food and Drug Administration (FDA) for use in the U.S. This test promises to bring greater confidence to cardiac care. This new biomarker revolutionizes cardiac care by identifying lower levels of troponin with excellent precision. Cardiac troponin is released into the bloodstream when cardiac muscle cells are being damaged, as when a heart attack occurs. Troponin is the preferred biomarker when attempting to diagnose a heart attack in clinical practice. As you will note, the Troponin is on the far right of the illustration and is one of the biomarkers that is tested when a heart attack is suspected. The TnT Gen 5 STAT will help physicians find this marker much more quickly than ever before, which is expected to reduce the amount of irreversible muscle cell damage that may occur